[
    [
        {
            "time": "",
            "original_text": "【华泰医药代雯团队】乐普医疗 (300003.SZ, 买入) 事件点评：免疫治疗再下一城，外科器械锦上添花",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "免疫治疗",
                    "外科器械"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【华泰医药代雯团队】乐普医疗 (300003.SZ, 买入) 事件点评：免疫治疗再下一城，外科器械锦上添花",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【乐普医疗】公告点评：参股美国Regenix公司，完善肿瘤免疫治疗布局",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "参股",
                    "Regenix",
                    "肿瘤免疫治疗"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物技术"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【乐普医疗】公告点评：参股美国Regenix公司，完善肿瘤免疫治疗布局",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "乐普医疗：进一步布局肿瘤治疗 加码外科器械",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "肿瘤治疗",
                    "外科器械"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "乐普医疗：进一步布局肿瘤治疗 加码外科器械",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "仿制药概念走弱 华海药业跌停",
            "features": {
                "keywords": [
                    "仿制药",
                    "华海药业",
                    "跌停"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "仿制药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "仿制药概念走弱 华海药业跌停",
                "Correlation": 3,
                "Sentiment": 2,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "总募资59.3亿元！创业板最大规模IPO结果揭晓 迈瑞医疗冲刺创业板一哥",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "IPO",
                    "创业板",
                    "募资"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "总募资59.3亿元！创业板最大规模IPO结果揭晓 迈瑞医疗冲刺创业板一哥",
                "Correlation": 2,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]